The NYU Cancer Institute (NYUCI), previously known as the Rita J. and Stanley H. Kaplan Comprehensive Cancer Center (KCCC), is a university based matrix organization, located principally on the main campus of the NYU Medical Center in mid-town Manhattan. In the last three years, the NYUCI has received greatly increased support from its parent organizations, the NYU School of Medicine and the NYU Hospitals Center and has gone through intensive strategic planning to achieve its present integration of basic, translational, clinical, and population science. With this expansion of its role, the KCCC was accorded """"""""Institute"""""""" status. Five formal Basic Science Programs are presented. Three of these, Environmental & Molecular Carcinogenesis, Growth Control & Tumor Immunology, have been included in prior CCSG application; however, each has added new areas to complement previous strengths and, in the case of the latter two, are either being led by or have added new members who have revitalized the Programs. Cancer Neurobiology and Stem Cell Biology represent the culmination of new initiatives resulting from the bringing together new members of the NYUCI into collaborations with senior scientists of the NYU School of Medicine and its Skirball Institute of Biomolecular Medicine. One additional Basic Science Program, in the area of Endothelial Research, is in development. Two multi-disciplinary, Disease-Oriented Programs, in Breast & Genitourinary Cancer, represent our emphasis on therapeutic and translational research. Four others, Neuro-oncology, Gynecologic Oncology, Gastrointestinal Oncology & Cutaneous Malignancies, are in development. Finally, one Population Science Program, Molecular Epidemiology & Prevention, demonstrates a broad range of interests in the identification of cancer risk factors and the translation of such knowledge into preventive and clinical interventions at the population level. In addition, nine Shared Resources are presented, with two others in development. Developmental funds for pilot studies, recruitment of new investigators and the establishment of new shared resources are also requested.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016087-25
Application #
6891641
Study Section
Subcommittee G - Education (NCI)
Program Officer
Silkensen, Shannon M
Project Start
1975-06-30
Project End
2008-02-28
Budget Start
2005-03-01
Budget End
2006-02-28
Support Year
25
Fiscal Year
2005
Total Cost
$2,574,969
Indirect Cost
Name
New York University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016
Wang, Shiyang; Liechty, Benjamin; Patel, Seema et al. (2018) Programmed death ligand 1 expression and tumor infiltrating lymphocytes in neurofibromatosis type 1 and 2 associated tumors. J Neurooncol 138:183-190
Nancy, Patrice; Siewiera, Johan; Rizzuto, Gabrielle et al. (2018) H3K27me3 dynamics dictate evolving uterine states in pregnancy and parturition. J Clin Invest 128:233-247
Schulfer, Anjelique F; Battaglia, Thomas; Alvarez, Yelina et al. (2018) Intergenerational transfer of antibiotic-perturbed microbiota enhances colitis in susceptible mice. Nat Microbiol 3:234-242
Ge, Wenzhen; Clendenen, Tess V; Afanasyeva, Yelena et al. (2018) Circulating anti-Müllerian hormone and breast cancer risk: A study in ten prospective cohorts. Int J Cancer 142:2215-2226
Ruggles, Kelly V; Wang, Jincheng; Volkova, Angelina et al. (2018) Changes in the Gut Microbiota of Urban Subjects during an Immersion in the Traditional Diet and Lifestyle of a Rainforest Village. mSphere 3:
Winer, Benjamin Y; Shirvani-Dastgerdi, Elham; Bram, Yaron et al. (2018) Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infection. Sci Transl Med 10:
Gupta, Ankit; Xu, Jing; Lee, Shirley et al. (2018) Facile target validation in an animal model with intracellularly expressed monobodies. Nat Chem Biol 14:895-900
Marié, Isabelle J; Chang, Hao-Ming; Levy, David E (2018) HDAC stimulates gene expression through BRD4 availability in response to IFN and in interferonopathies. J Exp Med 215:3194-3212
Evensen, Nikki A; Madhusoodhan, P Pallavi; Meyer, Julia et al. (2018) MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemia. Haematologica 103:830-839
Lee, Hyun-Wook; Park, Sung-Hyun; Weng, Mao-Wen et al. (2018) E-cigarette smoke damages DNA and reduces repair activity in mouse lung, heart, and bladder as well as in human lung and bladder cells. Proc Natl Acad Sci U S A 115:E1560-E1569

Showing the most recent 10 out of 1170 publications